MedPath

PROSPECTIVE RANDOMIZED DOUBLE-BLINDED PLACEBO CONTROLLED TRAIL STUDYING EFFICACY IN TERMS OF BLOOD LOSS AND SAFETY IN TERMS DVT OF INTRA-ARTICULAR TRANEXAMIC ACID IN UNILATERAL TOTAL KNEE ARTHROPLASTY.

Not Applicable
Conditions
Health Condition 1: null- Patients with Osteoarthritis knee
Registration Number
CTRI/2015/09/006185
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients diagnosed with osteoarthritis scheduled for unilateral cemented TKA, either sex, aged <80 years

Exclusion Criteria

Revision TKR/ Bilateral TKR

Known or suspected allergy to medication

Inherited or acquired hemostatic disease

Abnormal coagulation screening test(platelet count, prothrombin time, APTT)

Ingestion of aspirin within seven days of surgery

Renal / Hepatic insufficiency

Pregnancy

History of DVT or Pulmonary embolism

History of ocular pathology or ophthalmological procedures other then corrective lenses

History of haematuria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood Loss, measured by drain output drop in Hb and PCV,safety assessed by B/L lower limb dopplerTimepoint: Blood Loss, measured by drain output at 6hr,24hr, and 48hr post operatively, drop in Hb and PCV at post operative day 0,day 1,day 7 and day 14,no.of patient require blood transfusion,safety assessed by B/L lower limb doppler at 7th post operative day ,6th week and 3rd month.
Secondary Outcome Measures
NameTimeMethod
Requirement of blood transfusion , safetyTimepoint: Course of inpatient stay after total knee arthroplasty and follow up for 3 months
© Copyright 2025. All Rights Reserved by MedPath